It was also demonstrated that PTPRD could regulate PD-L1 via its effects on STAT3 in human hepatocellular carcinoma, and consequently, enhanced STAT3 activity may support tumor immune evasion [51]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.